| 1 |
Sanyaolu A, Marinkovic A, Abbasi AF, Prakash S, Patidar R, Desai P, Williams M, Jan A, Hamdy K, Solomon R, Balendra V, Ansari M, Shazley O, Khan N, Annan R, Dixon Y, Okorie C, Antonio A. Effect of SARS-CoV-2 infection on the liver. World J Virol 2023; 12(2): 109-121 [DOI: 10.5501/wjv.v12.i2.109] [Reference Citation Analysis]
|
| 2 |
Gildea DT, Woo SM, O'Connor CE, Rangnekar AS. COVID-19-Associated Liver Injury. Hepat Med 2023;15:1-9. [PMID: 36852138 DOI: 10.2147/HMER.S384108] [Reference Citation Analysis]
|
| 3 |
Cheung KS, Lam LK, Mao X, Tan JT, Ooi PH, Zhang R, Chan KH, Hung IFN, Seto WK, Yuen MF. Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients. Vaccines 2023;11:497. [DOI: 10.3390/vaccines11030497] [Reference Citation Analysis]
|
| 4 |
Lempesis IG, Karlafti E, Papalexis P, Fotakopoulos G, Tarantinos K, Lekakis V, Papadakos SP, Cholongitas E, Georgakopoulou VE. COVID-19 and liver injury in individuals with obesity. World J Gastroenterol 2023; 29(6): 908-916 [DOI: 10.3748/wjg.v29.i6.908] [Reference Citation Analysis]
|
| 5 |
Yang R, Feng J, Wan H, Zeng X, Ji P, Zhang J. Liver injury associated with the severity of COVID-19: A meta-analysis. Front Public Health 2023;11:1003352. [PMID: 36817905 DOI: 10.3389/fpubh.2023.1003352] [Reference Citation Analysis]
|
| 6 |
Zanon M, Neri M, Pizzolitto S, Radaelli D, Concato M, Peruch M, D'Errico S. Liver pathology in COVID-19 related death and leading role of autopsy in the pandemic. World J Gastroenterol 2023; 29(1): 200-220 [PMID: 36683722 DOI: 10.3748/wjg.v29.i1.200] [Reference Citation Analysis]
|
| 7 |
Saha L, Vij S, Rawat K. Liver injury induced by COVID 19 treatment – what do we know? World J Gastroenterol 2022; 28(45): 6314-6327 [DOI: 10.3748/wjg.v28.i45.6314] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Dividis GP, Papadopoulos GE, Karageorgiou I, Kotronis G. Remdesivir-Induced Liver Injury in a Patient With Coronavirus Disease 2019 and History of Congestive Hepatopathy. Cureus 2022. [DOI: 10.7759/cureus.32353] [Reference Citation Analysis]
|
| 9 |
Pal M, Muinao T, Parihar A, Roy DK, Boruah HPD, Mahindroo N, Khan R. Biosensors based detection of novel biomarkers associated with COVID-19: Current progress and future promise. Biosens Bioelectron X 2022;12:100281. [PMID: 36405494 DOI: 10.1016/j.biosx.2022.100281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Cooper KM, Colletta A, Asirwatham AM, Moore Simas TA, Devuni D. COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes. World J Gastroenterol 2022; 28(42): 6017-6033 [DOI: 10.3748/wjg.v28.i42.6017] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Alnamshan MM. Potential histopathological and immunological effects of SARS-CoV-2 on the liver. Braz J Biol 2022;82:e262008. [PMID: 36074418 DOI: 10.1590/1519-6984.262008] [Reference Citation Analysis]
|
| 12 |
Yilmaz AE. How reliable are the multiple comparison methods for odds ratio? Journal of Applied Statistics. [DOI: 10.1080/02664763.2022.2104229] [Reference Citation Analysis]
|
| 13 |
Du M, Yang S, Liu M, Liu J. COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms. Clin Res Hepatol Gastroenterol 2022;46:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 14 |
Mohammed SA, Eid KM, Anyiam FE, Wadaaallah H, Muhamed MAM, Morsi MH, Dahman NBH. Liver injury with COVID-19: laboratory and histopathological outcome—systematic review and meta-analysis. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00171-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Tarasova L, Malyavin A, Busalaeva E, Tsyganova Y, Komarova E. Hyperammonemia is a risk factor for poor outcomes in patients with COVID-19. Dok gastroenterol 2022;11:39. [DOI: 10.17116/dokgastro20221102139] [Reference Citation Analysis]
|
| 16 |
Kayaaslan B, Guner R. COVID-19 and the liver: A brief and core review. World J Hepatol 2021;13:2013-23. [PMID: 35070005 DOI: 10.4254/wjh.v13.i12.2013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Liemarto AK, Budiono BP, Chionardes MA, Oliviera I, Rahmasiwi A. Liver abscess with necrosis in post COVID-19: A case report. Ann Med Surg (Lond) 2021;72:103107. [PMID: 34840781 DOI: 10.1016/j.amsu.2021.103107] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Abdelrahman MM, Abdel-Baset AA, Younis MA, Mahmoud MG, Shafik NS. Liver function test abnormalities in COVID-19 patients and factors affecting them - a retrospective study. Clin Exp Hepatol 2021;7:297-304. [PMID: 34712832 DOI: 10.5114/ceh.2021.109225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Harapan H, Fajar JK, Supriono S, Soegiarto G, Wulandari L, Seratin F, Prayudi NG, Dewi DP, Monica Elsina MT, Atamou L, Wiranata S, Aprianto DP, Friska E, Sari Firdaus DF, Alaidin M, Wardhani FA, Husnah M, Hidayati NW, Hendriyanti Y, Wardani K, Evatta A, Manugan RA, Pradipto W, Rahmawati A, Tamara F, Mahendra AI, Nainu F, Santoso B, Irawan Primasatya CA, Tjionganata N, Budiman HA. The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta-analysis. Rev Med Virol 2021;:e2304. [PMID: 34643006 DOI: 10.1002/rmv.2304] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Groiss S, Pabst D, Faber C, Meier A, Bogdoll A, Unger C, Nilges B, Strauss S, Föderl-höbenreich E, Hardt M, Geipel A, Reinecke F, Korfhage C, Zatloukal K. Highly resolved spatial transcriptomics for detection of rare events in cells.. [DOI: 10.1101/2021.10.11.463936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Sodeifian F, Seyedalhosseini ZS, Kian N, Eftekhari M, Najari S, Mirsaeidi M, Farsi Y, Nasiri MJ. Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review. Front Med (Lausanne) 2021;8:731436. [PMID: 34616757 DOI: 10.3389/fmed.2021.731436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 22 |
Wilairatana P, Masangkay FR, Kotepui KU, Milanez GJ, Kotepui M. Prevalence and characteristics of malaria among COVID-19 individuals: A systematic review, meta-analysis, and analysis of case reports. PLoS Negl Trop Dis 2021;15:e0009766. [PMID: 34597315 DOI: 10.1371/journal.pntd.0009766] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 23 |
Rashedi S, Keykhaei M, Pazoki M, Ashraf H, Najafi A, Kafan S, Peirovi N, Najmeddin F, Jazayeri SA, Kashani M, Moharari RS, Montazeri M. Clinical significance of prognostic nutrition index in hospitalized patients with COVID-19: Results from single-center experience with systematic review and meta-analysis. Nutr Clin Pract 2021;36:970-83. [PMID: 34270114 DOI: 10.1002/ncp.10750] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 24 |
Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. World J Hepatol 2021;13:1143-53. [PMID: 34630881 DOI: 10.4254/wjh.v13.i9.1143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 25 |
Malekifar P, Pakzad R, Shahbahrami R, Zandi M, Jafarpour A, Rezayat SA, Akbarpour S, Shabestari AN, Pakzad I, Hesari E, Farahani A, Soltani S. Viral Coinfection among COVID-19 Patient Groups: An Update Systematic Review and Meta-Analysis. Biomed Res Int 2021;2021:5313832. [PMID: 34485513 DOI: 10.1155/2021/5313832] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 26 |
Kravchuk YA. Features of management of patients with liver diseases in the conditions of the COVID-19 pandemic. Russian Military Medical Academy Reports 2021;40:57-62. [DOI: 10.17816/rmmar76270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 27 |
Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 28 |
Srivastava S, Garg I. Post COVID-19 infection: Long-term effects on liver and kidneys. World J Meta-Anal 2021; 9(3): 220-233 [DOI: 10.13105/wjma.v9.i3.220] [Reference Citation Analysis]
|
| 29 |
Bende F, Tudoran C, Sporea I, Fofiu R, Bâldea V, Cotrău R, Popescu A, Sirli R, Ungureanu BS, Tudoran M. A Multidisciplinary Approach to Evaluate the Presence of Hepatic and Cardiac Abnormalities in Patients with Post-Acute COVID-19 Syndrome-A Pilot Study. J Clin Med 2021;10:2507. [PMID: 34204032 DOI: 10.3390/jcm10112507] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 30 |
Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients. World J Virol 2021; 10(3): 86-96 [PMID: 34079691 DOI: 10.5501/wjv.v10.i3.86] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 31 |
Grinevich VB, Kravchuk YA, Ped VI, Sas EI, Salikova SP, Gubonina IV, Tkachenko EI, Sitkin SI, Lazebnik LB, Golovanova EV, Belousova EA, Makarchuk PA, Eremina EY, Sarsenbaeva AS, Abdulganieva DI, Tarasova LV, Gromova OA, Ratnikov VA, Kozlov KV, Ratnikova AK. Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition). jour 2021. [DOI: 10.31146/1682-8658-ecg-187-3-5-82] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 32 |
Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 [PMID: 33833483 DOI: 10.3748/wjg.v27.i13.1296] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 33 |
Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World J Gastroenterol 2021; 27(5): 377-390 [PMID: 33584070 DOI: 10.3748/wjg.v27.i5.377] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 38] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 34 |
Ng A. Graft injury and re-transplantation in liver transplant patients with COVID-19. Journal of Liver Transplantation 2021;1:100008. [DOI: 10.1016/j.liver.2021.100008] [Reference Citation Analysis]
|
| 35 |
Liu Y, Li M, Liu D, Luo JF, Li N, Zhang X, Tang XJ, Zhang X, Liu J, Wang J, Wang T, Zhou YZ, Luo WX, Liang ZA, Luo FM, Li WM, Wang G. Developing a multivariable risk prediction model to predict prolonged viral clearance in patients with COVID-19. J Infect 2021;82:e20-2. [PMID: 33387568 DOI: 10.1016/j.jinf.2020.12.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 36 |
Fierro NA. COVID-19 and the liver: What do we know after six months of the pandemic? Ann Hepatol 2020;19:590-1. [PMID: 32956871 DOI: 10.1016/j.aohep.2020.09.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
|
